ICON CLINICAL RESEARCH UK LIMITED
Company Information
- Company Number
- 02541764
- Registered Address
- 500 South Oak Way Green Park, Reading, England, RG2 6AD
- Status
- Active
- Employee Count
- 555.0
- Turnover
- 67945000.0
- EBITDA
- -8657000.0
Additional Details
- Website
- https://iconplc.com
- Company Type
- Private limited Company
- Incorporated On
- 21 September 1990
- Nature of Business
- 72190 - Other research and experimental development on natural sciences and engineering
- Industries
- 0
- Region
- South East
Company Location
Financial Metrics
Time to Pay
Payment Timeline
Payment Features
Payment Time Trends
Payment Distribution Trends
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 15 | 93% | 5% | 2% | 5% |
| 01 Jan 2023 - 30 Jun 2023 | 20 Jul 2023 | 21 | 89% | 8% | 3% | 10% |
| 01 Jul 2022 - 31 Dec 2022 | 11 Jan 2023 | 19 | 91% | 7% | 2% | 7% |
| 01 Jan 2022 - 30 Jun 2022 | 29 Jul 2022 | 16 | 93% | 5% | 2% | 7% |
| 01 Jul 2021 - 31 Dec 2021 | 25 Jan 2022 | 16 | 91% | 7% | 2% | 9% |
| 01 Jan 2021 - 30 Jun 2021 | 22 Jul 2021 | 20 | 89% | 7% | 4% | 10% |
| 01 Jul 2020 - 31 Dec 2020 | 28 Jan 2021 | 15 | 93% | 5% | 2% | 7% |
| 01 Jan 2020 - 30 Jun 2020 | 07 Aug 2020 | 16 | 90% | 6% | 4% | 10% |
| 01 Jul 2019 - 31 Dec 2019 | 28 Jan 2020 | 18 | 90% | 5% | 5% | 10% |
| 01 Jan 2019 - 30 Jun 2019 | 25 Jul 2019 | 19 | 84% | 9% | 7% | 16% |
| 01 Jul 2018 - 31 Dec 2018 | 24 Jan 2019 | 21 | 90% | 5% | 5% | 10% |
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 | 19 | 93% | 5% | 2% | 7% |
Company Summary
ICON Clinical Research (U.K.) Limited is a leading global provider of clinical research services, serving the pharmaceutical, biotechnology, and medical device industries
They offer a comprehensive range of services including clinical trial management, data management, medical affairs, and regulatory consulting
As a company committed to sustainability, ICON has implemented a number of initiatives to reduce their environmental impact
This includes reducing waste and energy consumption, promoting sustainable travel options for their employees, and using eco-friendly materials in their operations
Their products and services are focused on conducting clinical trials and gathering data to help their clients bring new medicines and treatments to market
They also provide consulting services to assist with regulatory approvals and compliance
The key people at ICON include the CEO, Dr
Steve Cutler, who has over 30 years of experience in the pharmaceutical industry, and the Chief Medical Officer, Dr
Nuala Murphy, who has a background in medicine and clinical research
Their website address is www.iconplc.com and their registered office address is South County Business Park, Leopardstown, Dublin 18, Ireland
They also have offices in the UK, US, and other countries around the world
Company Review
Trend Analysis
The average time to pay for ICON CLINICAL RESEARCH (U.K.) LIMITED has generally decreased over the past three periods, with a slight increase in the most recent period. The percentage of invoices paid within 30 days has also remained relatively consistent, with a slight drop in the most recent period. There has been a slight increase in the percentage of invoices paid between 31 and 60 days, and a decrease in the percentage of invoices paid later than 60 days. Overall, there has been a trend towards earlier payment for this company.
Volatility Analysis
The volatility for ICON CLINICAL RESEARCH (U.K.) LIMITED has been relatively low, with minor fluctuations in the average time to pay and the percentages of invoices paid within different time periods. The most volatile aspect appears to be the percentage of invoices paid later than 60 days, with a high of 7% in the first period and a low of 2% in the most recent period.
Summary Analysis
From 2018 to 2023, ICON CLINICAL RESEARCH (U.K.) LIMITED has shown a trend towards earlier payment, with a slight increase in the most recent period. The average time to pay has decreased from 19 days in 2018 to 15 days in 2023. The percentage of invoices paid within 30 days has remained consistently high, with a low of 89% in 2021 and a high of 93% in 2018 and 2022. The percentage of invoices paid between 31 and 60 days has fluctuated between 5% and 9%, while the percentage of invoices paid later than 60 days has decreased from 7% in 2018 to 2% in 2023. The company has consistently paid all invoices within the agreed terms, with a shortest (or only) standard payment period of 0 days.
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Once invoice gets due (based on the payment terms), they are included in the weekly payment schedules
Were there any changes to the standard payment terms in the reporting period?
No
Any other information about payment terms
N/A
Maximum contractual payment period agreed
60
Dispute Resolution Process
Suppliers can contact the central accounts payable email to raise any issues or disputes they may have. All queries are dealt with by the accounts payable team in a timely manner. All issues and disputes are escalated internally to management when necessary. Business contacts are available to suppliers on request.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available